--:--:--
Stockwatch Reports
…

News Reports / Technology / PLXS

PLXSPlexus Corp.

NasdaqGS · Technology · Mkt cap $5.8B · Avg vol 260.75K

$217.99

-21.35 (-8.92%)

Quote as of October 29, 2026, 2:55 PM ET

News Impact Report · Published October 29, 2026, 10:15 AM ET

PLXS: Plexus Corp Posts Q3 FY2026 Net Income of $121.5M as Shares Slide Over 9%

Share

Ticker: PLXS | Filing: 8-K (Items 2.02, 9.01) | Filed with the SEC on: October 28, 2026 | Current Price: $217.00 | Today's Change: -9.33%


What Happened

Plexus Corp filed an 8-K with the SEC on October 28, 2026, disclosing its financial results for the third quarter of fiscal year 2026 under Item 2.02 (Results of Operations and Financial Condition). The filing reveals quarterly revenue of approximately $2.97 billion, net income of $121.5 million, and operating income of $149.3 million for Q3 FY2026. On a per-share basis, the company reported basic EPS of $4.48 and diluted EPS of $4.39 for the quarter — figures that reflect a period of operationally meaningful profitability for the electronic manufacturing services provider.

Note on structured data: The XBRL data provided also includes a legacy revenue figure of -$154.8 million labelled FY2014, which appears to be a reclassification or prior-period adjustment entry in the filing's structured data. This report does not treat that figure as a current operating result.


Why It Matters

Despite reporting solid headline profitability — over $121 million in net income and nearly $150 million in operating income — shares of PLXS are down sharply on the day, falling more than 9% to $217.00. This kind of divergence between reported earnings and stock price reaction typically signals one of several things: results that missed consensus expectations, guidance that disappointed, or broader macro or sector-level selling pressure. The magnitude of the single-day drop is notable and suggests the market interpreted something in the full release — whether forward guidance, margin trajectory, or revenue composition — as materially weaker than anticipated. This coincides with StockWatch's initiating coverage on the company, published October 29, 2026, which investors may wish to consult for additional context on the longer-term fundamental picture.


Analysis

On the surface, Plexus's Q3 FY2026 numbers look operationally healthy. A diluted EPS of $4.39 and operating income of $149.3 million on revenues of approximately $2.97 billion implies an operating margin in the neighborhood of 5% — consistent with what is typical in the contract electronics manufacturing (EMS) space, where margins are structurally thin due to the pass-through nature of materials costs.

The sharp sell-off, however, directs attention away from the quarterly print itself and toward whatever forward-looking signals accompanied this release. Key things to watch going forward include:

  • Revenue growth trajectory: Whether the ~$2.97B quarterly revenue represents acceleration or deceleration relative to prior quarters.
  • Operating leverage: Whether operating income growth is keeping pace with or outrunning revenue growth — the $149.3M operating figure relative to the revenue base will be worth tracking in subsequent quarters.
  • Guidance and macro exposure: Plexus serves customers in healthcare, industrial, and aerospace/defense end markets. Any commentary on demand softness or supply chain shifts in those verticals would be significant.
  • The legacy data anomaly: The -$154.8M FY2014 revenue figure embedded in the XBRL data warrants clarification from the company — though it is unlikely to have operational significance today, unusual structured data entries occasionally reflect material restatements or reclassifications.

The -9.33% single-day move is large enough to demand scrutiny of the full earnings release, investor call transcript, and any updated guidance figures that accompanied the 8-K filing.


Disclaimer

This report is a news and informational summary based solely on data contained in the referenced SEC filing and its associated XBRL structured facts. It does not constitute investment advice, and no rating or price target is issued herein. Investors should conduct their own due diligence and consult a qualified financial adviser before making any investment decision. Past performance is not indicative of future results.

Existing Coverage

StockWatch has full coverage on PLXS, published 2026-10-29. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-10-28. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/785786/000078578626000062/plxs-20261028.htm

StockWatch initiated coverage · October 29, 2026

PLXS: Plexus Corp — Complex Manufacturing Partner Leveraging Healthcare and Aerospace Demand

Valuation reset from peak levels: At $223.89, PLXS sits roughly 27% below its 52-week high of $307.06 but about 70% above its 52-week low of $132.03. The stock's -6.46% single-day move on light volume (74,083 shares vs. a 0.26M average) suggests a headline-driven repricing rather than a fundamental break, leaving a $5.8B market cap on $6.77 of trailing EPS — a P/E of roughly 33x.

-2.6%

Read the full report →

-2.6%

Key Data

Last

$217.00

P&L ($)

$-22.34

P&L (%)

-9.33%

Day Range

$212.34 - $232.64

Volume

120.04K

Market Cap

$5.8B

Previous Close

$239.34

Open

$231.24

52 Week Range

$132.03 - $307.06

Shares Outstanding

26.65M

Public Float

26.27M

Average Volume

260.75K

As of October 29, 2026, 11:05 AM ET

Advertise here
Stockwatch Reports

Free stock market updates, top gainers & losers, and AI-generated stock analyses — updated daily. Real-time price movements, quotes, and coverage for German & U.S. stoc